BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

841 related articles for article (PubMed ID: 11467622)

  • 1. Hepatic Encephalopathy.
    Blei AT; Córdoba J;
    Am J Gastroenterol; 2001 Jul; 96(7):1968-76. PubMed ID: 11467622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of chronic hepatic encephalopathy.
    Morgan MY
    Hepatogastroenterology; 1991 Oct; 38(5):377-87. PubMed ID: 1662661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
    Tromm A; Griga T; Greving I; Hilden H; Hüppe D; Schwegler U; Micklefield GH; May B
    Hepatogastroenterology; 2000; 47(32):473-7. PubMed ID: 10791216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic encephalopathy: nomenclature, pathogenesis and treatment.
    Quero Guillén JC; Carmona Soria I; García Montes JM; Jiménez Sáenz M; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 2003 Feb; 95(2):135-42, 127-34. PubMed ID: 12760720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of portal systemic encephalopathy: standard and new treatments.
    Marín E; Uribe M
    Rev Invest Clin; 1990 Jul; 42 Suppl():141-8. PubMed ID: 19256154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic management of hepatic encephalopathy].
    Helewski KJ; Kowalczyk-Ziomek GI; Konecki JJ
    Wiad Lek; 2002; 55(5-6):301-9. PubMed ID: 12235697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
    Sharma P; Sharma BC; Sarin SK
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):526-31. PubMed ID: 20009938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment.
    Van Thiel DH; Fagiuoli S; Wright HI; Chien MC; Gavaler JS
    Hepatology; 1994 Jan; 19(1):67-71. PubMed ID: 8276369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients.
    Bajaj JS; Sanyal AJ; Bell D; Gilles H; Heuman DM
    Aliment Pharmacol Ther; 2010 May; 31(9):1012-7. PubMed ID: 20136802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic encephalopathy: pathophysiology and advances in therapy.
    Av SP
    Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and emerging strategies for treating hepatic encephalopathy.
    Foster KJ; Lin S; Turck CJ
    Crit Care Nurs Clin North Am; 2010 Sep; 22(3):341-50. PubMed ID: 20691385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal hepatic encephalopathy.
    Sharma P
    J Assoc Physicians India; 2009 Nov; 57():760-3. PubMed ID: 20329443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is the "specific" treatment of acute hepatic encephalopathy during liver cirrhosis justified?].
    Doffoël M; Vetter D
    Gastroenterol Clin Biol; 1994; 18(12):1055-6. PubMed ID: 7750676
    [No Abstract]   [Full Text] [Related]  

  • 14. [The dietary protein contribution and hepatic encephalopathy in cirrhosis].
    Zavaglia C; Brivio M; Losacco E; Onida L
    Recenti Prog Med; 1992 Apr; 83(4):218-23. PubMed ID: 1626117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of hepatic encephalopathy in the hospital.
    Leise MD; Poterucha JJ; Kamath PS; Kim WR
    Mayo Clin Proc; 2014 Feb; 89(2):241-53. PubMed ID: 24411831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal hepatic encephalopathy.
    Stewart CA; Smith GE
    Nat Clin Pract Gastroenterol Hepatol; 2007 Dec; 4(12):677-85. PubMed ID: 18043677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hepatic encephalopathy after portal shunt in the patient with cirrhosis].
    Grange D; Bismuth H
    Arch Fr Mal App Dig; 1975; 64(3):257-69. PubMed ID: 1108827
    [No Abstract]   [Full Text] [Related]  

  • 19. Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose.
    Riggio O; Balducci G; Ariosto F; Merli M; Tremiterra S; Ziparo V; Capocaccia L
    Hepatogastroenterology; 1990 Oct; 37(5):524-7. PubMed ID: 2253931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic encephalopathy. Physiopathology and treatment].
    Perney P; Pomier-Layrargues G
    Gastroenterol Clin Biol; 1994; 18(12):1069-76. PubMed ID: 7750679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 43.